Cencora's stock outperformed the general market index (S&P 500) on September 5, 2025.
3 reports, 2 independent
Updated Sep 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cencora's stock outperformed the general market index (S&P 500) on September 5, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cencora
US drug wholesale company company
Related events
Coverage
Newest first; wire copies grouped- ZacksHere's Why You Should Hold Cencora Stock in Your Portfolio Now Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, in
- Simply Wall St.Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend Cencora recently announced strong third-quarter earnings with sales at $80,664 million and net income rising to $687 million, refl
- ZacksHere's Why You Should Add Cencora Stock to Your Portfolio Now Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, int